Context: Postprandial glucose homeostasis is regulated through the secretion of glucagon-like peptide 1 (GLP-1) through the stimulation of insulin secretion and inhibition of glucagon secretion. However, how these processes dynamically adapt to demands created by caloric challenges achieved during daily life is not known.
regulation of GLP-1 and insulin secretion in relation to glucose loads seems to exist, the purpose of which is to assure identical glucose levels, which may be a key factor for glycemic control. A similarly increased incretin hormone and insulin secretion with increased caloric challenges after ingestion of a mixed meal would be important for glucose homeostasis in regular daily life. In one study, Vilsbøll et al (5) demonstrated that the GLP-1, glucosedependent insulinotropic polypeptide (GIP), and insulin responses were more pronounced after a 520-kcal breakfast meal compared with a 260-kcal breakfast in obese subjects, whereas the glucose profiles were similar after the two meals, indicating an adaptation of insulin and incretin hormones also after mixed meal ingestion.
However, although this study showed increased secretion of incretin hormones and insulin after increased caloric content during a breakfast, whether incretin hormones and the ␤-cells respond with sufficiently increased secretion after meals ingested at more regular daily life times and of more typical sizes is not known. This is important because 260-and 520-kcal meals are not representative of a normal lunch or dinner, when most subjects ingest their highest caloric meal (6) . Therefore, it is still not known whether there is an incretin and islet hormone adaptation to meal ingestion in normal physiology.
This fundamental question was explored in this study in which we analyzed the postlunch response of GLP-1, GIP, and ␤-cell function to three lunch meals with identical nutritional composition but with different size (511, 743, and 1034 kcal), being representative of the recommended range of normal lunch calories (7) . Meals were ingested at the same time of the day (noon) after a standardized breakfast at 8:00 AM (ie, standardized lunch time and prelunch fast). With this experimental design, we could ascertain whether the increase in incretin hormone and insulin secretion by increasing caloric load: 1) is present only after a full overnight fast (ie, at breakfast) or is evident at the typical lunch time, after a physiological 4-hour fast from breakfast, which is important, considering that the ␤-cells have a memory effect after its preceding stimulation (8) and that incretin hormones are subjected to diurnal variations (9); 2) is evident also after extending the caloric content of the meals to what is typically seen in daily life or is restricted to minimal caloric loads and is therefore saturable; and 3) is restricted to carbohydrate-based breakfasts or oral glucose or is seen also after ingestion of mixed meals with a composition more typical of daily life. We also examined glucagon levels because it is not known whether glucagon secretion also is adaptively regulated by meal size, and we related the findings to the possible effects of gastric emptying by analyzing paracetamol kinetics (10).
Subjects and Methods

Subjects
This was a single-center study involving 24 healthy lean subjects, 12 men and 12 women, being 20 -28 years old [mean age 25 Ϯ 2 y (SD)]. They had no personal history of diabetes or gastrointestinal diseases. Body mass index was 20 -25 kg/m 2 (mean 22 Ϯ 1.4 kg/m 2 ). Six of the female subjects had combined contraceptive pills, two had progesterone only-pill, two had a single contraceptive implant, and two did not use hormone contraception. No other drugs were taken.
Ethics and good clinical practice
The study was approved by the Ethics Committee of the Lund University. All the subjects gave their written informed consent before entry into the study. The study was registered at www.clinicaltrials.gov (identification number NCT01366781). The study was conducted using good clinical practice and was in accordance with the Declaration of Helsinki.
Study protocol
All subjects ingested the three lunches of different size after a standardized breakfast, which was the same on all occasions. Thus, on three occasions in randomized order, separated by at least 3 weeks and maximally 6 weeks, and after an overnight fast, the subjects were served a standardized breakfast at 8:00 AM, consisting of 524 kcal (19% protein, 18% fat, 63% carbohydrate) as rye and white whole-meal bread (60 g), margarine (40% enriched Becel; 10 g), ham from smoked pork (fat 3%; 15 g), cheese (fat 17%; 15 g), juice (285 g), green paprika (40 g), light sour milk fat 0.5% enriched (200 g) and cereals mix-muesli with fruit (40 g). After the breakfast, the subjects had no food or drink until 12:00 PM, when they were served a lunch meal based on sirloin steak with the composition according to Supplemental Table 1 , containing 511 kcal, 743 kcal, or 1034 kcal on three different occasions. Meals were consumed within 10 -20 minutes. A tablet of paracetamol (1.5g; GlaxoSmithKline) dissolved in water was administered together with the lunch meals for analyses of paracetamol kinetics (10, 11) . All three meals had identical nutrient compositions [protein energy (E) 18%, fat E32%, and carbohydrates E50%]. The females did the challenge on the same day of the menstrual period. Blood samples were taken throughout a 300-minute period after lunch intake at time point t ϭ Ϫ5, Ϫ2, 5, 10, 20, 30, 45, 60, 75, 90, 120, 150, 180, 240, and 300 minutes.
Analysis
Blood samples for the assay of glucose, insulin, C-peptide, glucagon, and paracetamol were collected into chilled tubes containing EDTA (7.4 mmol/L) and aprotinin (500 KIU/mL; Novo Nordisk) and were immediately centrifuged at 4°C; plasma was frozen at Ϫ20°C until analysis. Glucose was measured using the glucose oxidase method. Insulin levels were analyzed using an ELISA (Mercodia Corp). Glucagon and C-peptide were analyzed using a double-antibody RIA (Linco Research). Blood samples for the determination of intact GLP-1 (iGLP-1) and intact GIP (iGIP) were collected into chilled tubes containing EDTA and aprotinin with the addition of the dipeptidyl peptidase-4 inhibitor diprotin A (0.1 mmol/L; Bachem). iGLP-1 and iGIP concentrations were determined with ELISA (Millipore Corp and De-meditec Diagnostics, respectively). Paracetamol was analyzed using a colorimetric assay (Cambridge Life Science).
Data analysis
The 0-to 180-minute areas under the curve (AUCs) were calculated using the trapezoid rule using results from all time points during the time period. ␤-Cell function was assessed from glucose and C-peptide using a model described previously (12) . The model provides the ␤-cell dose response, which relates insulin secretion (in picomoles per minute per square meter) to glucose concentration; the slope of the dose response is denoted as glucose sensitivity. The model also provides a parameter quantifying early insulin secretion (denoted as rate sensitivity), the potentiation factor, a function of time reflecting relative enhancement or inhibition of insulin secretion during the test, and total insulin secretion during the test. The model gives results every 5 minutes, ie, more values than blood sampling points. ␤-Cell function was also quantified using the insulinogenic index, calculated here for the whole 180-minute test as AUC c-peptide 180 minutes /AUC glucose 180 minutes (13, 14) . Insulin clearance (in liters per minute per square meter) was calculated as the ratio between the total insulin secretion and the insulin concentration AUC. The prehepatic insulin to glucagon molar concentration ratio, a variable quantifying the influence of islet hormones on hepatic glucose production (15, 16) , was estimated with the following formula (17) :
where ISR(t) is insulin secretion at time t, hPF is hepatic plasma flow, I(t) and Glg(t) are the measured peripheral plasma concentrations of insulin and glucagon at time t, and MCRGlg is the metabolic clearance rate of glucagon. hPF was estimated by multiplying the cardiac index (3. (20) . Paracetamol appearance (in micromoles per minute) was calculated by deconvolution,using the two-exponential model of paracetamol kinetics proposed by Rawlins et al. (11) .
From the rate of paracetamol appearance, the following three parameters were calculated: 1) the amount of paracetamol that appeared during the first 20 minutes (early paracetamol appearance) as a fraction of the recovered dose; 2) the amount of paracetamol appeared between 20 and 60 minutes (late paracetamol appearance) as a fraction of the recovered dose; and 3) the mean time of paracetamol appearance as the integral of the product of time and paracetamol appearance, divided by the recovered dose. These calculations were performed over a time period of 120 minutes because the rate of the paracetamol appearance was virtually zero after 2 hours. The models give estimates every 5 minutes, ie, more often than the blood samples were taken. Reported values are mean Ϯ SEM unless otherwise stated. A paired t test and a one-way Bonferroni compressions test were used to test the significance between the meals test. Relationships between variables were assessed using the Spearman correlation coefficient().
Results
Glucose
Plasma glucose rose from a baseline of approximately 4.5 mmol/L after all three meals to reach a peak after 30 minutes. For the two larger meals, the peak glucose levels were exactly the same (5.7 Ϯ 0.2 mmol/L), and after the peak, the values returned to baseline after 90 minutes (Figure 1) . In contrast, after the smaller meal, the glucose peak was somewhat lower (5.3 Ϯ 0.1 mmol/L), and, more importantly, there was a postpeak reduction below baseline to a nadir of 3.8 Ϯ 0.1 mmol/L after 75 minutes (P Ͻ .001) before the levels reached baseline. There were no differences in AUC glucose among the meals (Table 1) .
Insulin, C-peptide, and ␤-cell function
Plasma insulin and C-peptide concentrations increased after all three meals, with peaks at 30 minutes for insulin and at 45 minutes for C-peptide levels ( Figure 1 ). After the peak, insulin levels went down but were elevated in a calorie-dependent manner above baseline throughout study period (P Ͻ .001). The insulinogenic index, AUC insulin , and AUC C-peptide were significantly increased by increas- ing meal size ( Figure 1 and Table 1 ). Increasing the meal size produced also an increase in insulin secretory rate and ␤-cell glucose sensitivity, whereas the differences in the rate sensitivity did not reach statistical significance ( Figure  2 ). ␤-Cell glucose sensitivity was significantly higher after 1034 kcal (92
.001) but not different between 743 and 511 kcal. The ␤-cell potentiation factor showed the typical initial increase followed by a gradual return to baseline; with the higher caloric intake, the increase was progressively more sustained, and the 150-to 50-minute potentiation ratio was progressively increased (Figure 2 ). Insulin clearance decreased with meal size (Table 1) and was inversely related to total insulin secretion across all meals ( ϭ Ϫ0.50, P Ͻ .0001).
Incretin hormones
Intact GLP-1 concentrations increased after all three meals in a calorie-dependent manner (Figure 3 ). The 30-minute peak levels were 8.9 Ϯ 0.8 pmol/L after 511 kcal, 11.4 Ϯ 0.9 pmol/L after 743 kcal, and 16.0 Ϯ 1.5 pmol/L after 1034 kcal (P Ͻ .001). After the 30-minute peak, the levels of iGLP-1 decreased after all meals, although the levels remained above the baseline during the length of the study. The AUC iGLP-1 was significantly higher by increasing the caloric load in the meal (P ϭ .004; Table 1 ). iGIP concentrations increased from the baseline after meal ingestion with a peak at 60 minutes, ie, slightly later than the iGLP-1 peak. The peak iGIP levels were 71.1 Ϯ 5.0 pmol/L after 511 kcal, 82.0 Ϯ 5.4 pmol/L after 743 kcal, and 93.1 Ϯ 4.6 pmol/L after 1034 kcal (P ϭ .01). The AUC iGIP was significantly increased by increasing caloric load (Table  1 ). In the whole data set, the 180-minute incremental GLP-1 AUC was positively related to all model-derived ␤-cell function parameters, in a similar way ( ϭ approximately 0.25, P Ͻ .05). The relationships with GIP were not significant, with the exception of the potentiation ratio ( ϭ 0.35, P Ͻ .005).
Glucagon and prehepatic insulin to glucagon ratio
Plasma glucagon concentrations increased after meal ingestion with a peak level after 30 minutes, with no significant difference between meals (Figure 4) . After the peak, glucagon reached baseline after 60 minutes. After the 511-kcal meal, the glucagon levels increased between 60 and 75 minutes, ie, when glucose levels had fallen below baseline (by 28.5 Ϯ 1.5 pmol/L; P ϭ .02). The AUC glucagon did not differ between the meals (Table 1) . We also modeled the prehepatic insulin to glucagon molar ratio, a variable quantifying the influence of islet hormones on hepatic glucose production. The ratio increased after meal ingestion to a peak at 30 minutes ( Figure 4) ; the AUC increased by increasing the caloric loads (Table 1) .
Paracetamol
The average recovery of paracetamol in all studies was approximately 1.4 g, with no difference in paracetamol bioavailability between meals. However, as the meal size increased, the paracetamol appearance curve Figure 2 . Insulin secretory rate, the ␤-cell potentiation factor, and the ␤-cell dose response after ingestion of 511 kcal (F-F), 743 kcal (E-E), and 1034 kcal (‚-‚) mixed meal in healthy subjects (n ϭ 24). Means Ϯ SE are shown.
was shifted to the left ( Figure 4) ; thus, with larger meals, the mean appearance times were shorter, the early appearance was higher, and the late appearance was lower ( Table  1 ). The mean appearance time was strongly inversely related to early appearance ( ϭ Ϫ0.8, P Ͻ .0001). Across all meals, the pattern of paracetamol appearance was related to the GLP-1 response and to a lesser extent to the GIP response, as assessed by the 180-minute incremental hormone AUC. In particular, the GLP-1 response was directly related to early paracetamol appearance ( ϭ 0.48, P Ͻ .0001) and inversely to the mean appearance time ( ϭ Ϫ0.46, P Ͻ .0001). Thus, a higher early paracetamol appearance and shorter appearance time produced a stronger GLP-1 response. The results for GIP were similar but with weaker correlations ( ϭ Ϫ0.38, P Ͻ .001, and ϭ 0.19, P ϭ .1, for the early appearance and the mean appearance time, respectively).
Discussion
Metabolic adaptation to changing demands is required for normal homeostasis, and this is particularly so for glucose homeostasis because increasing caloric loads require higher insulin responses to avoid hyperglycemia. This has been shown after breakfast ingestion after an overnight fast when meals with different caloric loads were found to have very similar glucose responses but clearly different insulin responses, with higher insulin response after higher caloric intake being required to prevent hyperglycemia (5, 21, 22) . In the present study, we explored the responses of glucose, incretin hormones, and islet hormones after normal lunches of different calorie content but with exactly the same composition to establish the changes in glucose, incretin hormone, and islet hormone secretion after calorie demands created by different caloric loads as seen in daily life. The meals had a caloric content of 511 kcal, 743 kcal, and 1034 kcal with 60% of the energy from carbohydrates, 32% from fat, and 18% from protein. Meals were ingested at the same time of the day (noon) after a fixed fast of 4 hours after a standardized breakfast taken at 8:00 AM in the morning. Accounting for these factors is important because the ␤-cells have a memory effect after the preceding stimulation (8) , which has to be controlled for, and because secretion of incretin hormones shows a diurnal pattern (9) . The main findings of the study are as follows: 1) there is a clear augmentation of the responses of the incretin hormones after increased caloric ingestion at lunch; 2) for the two largest meals, this is translated into an adaptive increase in ␤-cell function and circulating insulin, which perfectly adapts to the caloric demand, resulting in identical glucose excur- jcem.endojournals.orgsions; and 3) the smaller mixed meal (511 kcal) resulted in a postpeak glucose reduction below baseline, which was restored in association with an increase in glucagon to prevent hypoglycemia. The augmentation in insulin secretion and ␤-cell function after meal ingestions could be explained by the dynamics of the incretin hormones because both GLP-1 and GIP increased in a caloric-dependent manner and because both GLP-1 and GIP are known to glucose dependently stimulate insulin secretion (23, 24) . The increase in incretin hormones by increased meal size might be explained by an increased nutrient exposure of K cells and L cells in the intestinal mucosa because both cells have been shown to respond to luminal carbohydrate, fat, and protein (23, 25) . Although the K cells are predominantly located in the proximal part of the intestinal tract, whereas L cells are primarily located in the distal part (26) , GLP-1 levels increased at the same time as GIP and the peak of GLP-1 was seen earlier than the peak GIP in all three meals. This would suggest a complex intergut mechanisms that may involve neural factors (27) but may also be explained by the occurrence of L cells also more proximally (26) . Therefore, although the study shows a clear physiological incretin hormone and insulin secretion adaptation to increasing caloric load after a normal lunch ingestion, which are also related to gastric emptying, the precise mechanism underlying this adaptation needs to be explored in future studies.
Insulin secretion was augmented by increasing caloric intake, as evident by the enhanced levels of insulin and C-peptide. Our results suggest that this is achieved by the higher incretin hormones, resulting in increased ␤-cell function (insulinogenic index) because the increase in glucose levels after meal ingestion was similar in the three meals and could not explain the difference. In addition to the direct measure (ie, insulinogenic index), this is also supported by the model analyses of insulin secretion, which showed increased ␤-cell glucose sensitivity after ingestion of the larger meal compared with the smaller meals. We also found that insulin clearance was reduced by increasing the meal size, which further adds to the hyperinsulinemia. The reduced insulin clearance may be explained by the augmented insulin secretion that yielded elevated C-peptide and insulin concentrations at the liver level. Stimulated insulin secretion with hyperinsulinemia has been shown to reduce hepatic insulin extraction (28 -30) and thus insulin clearance (31) . This is important because it has previously been shown that a reduction of insulin clearance contributes to the strong insulin response associated with the incretin effect in humans (32) . The incretin hormones may therefore indirectly contribute to reduced insulin clearance, which is supported by results in an experimental mouse model that GLP-1 reduces insulin clearance (33) .
Glucagon secretion was stimulated by all three meals, which may be explained by the protein in the meal and activation of the autonomic nervous system (34, 35) . However, there was no difference between the meals, suggesting that the ␣-cells are not subject to dynamic adaptation to the meal caloric content similar to that of the ␤-cells. Collectively, this resulted in turn in a higher estimated prehepatic insulin to glucagon ratio by increasing the caloric load, which is a reflection of a stronger islet signal to the liver to restrain the hepatic glucose release, which may be a major mechanism protecting from hyperglycemia after the largest meal. An interesting observation in the present study was that glucagon levels increased after a postpeak reduction of glucose below baseline at 60 -75 minutes after meal ingestion of the small meal. This would thus serve as a protection from hypoglycemia after a mixed meal of smaller size. The increase in glucagon at this stage after meal ingestion may be achieved by GIP because GIP has been shown to stimulate glucagon secretion at low glucose (36) and euglycemia (37) . The result thus demonstrated a finely tuned balance of insulin and glucagon to regulate glucose homeostasis in healthy subjects.
It is known that the rate of gastric emptying contributes to postprandial glucose control in healthy subjects (38) . In this study we evaluated gastric emptying after all meals by using the indirect paracetamol test. Although easy to perform and noninvasive, we acknowledge that this technique is not the best test for estimating gastric emptying (39); nonetheless, it has been validated by observing paracetamol appearance as the readout (10) . We found that the 0-to 20-minute paracetamol appearance was increased by increasing meal size as a sign of a rapid increase in early gastric emptying by increasing the size of a solid meal. This confirms previous results that increasing meal size increases gastric emptying (40, 41) ; this may be due to increased antral motility that results from activated gastric wall stretch and volume receptors (38, 41) . This rapid gastric emptying might have contributed to the higher incretin levels and the subsequent reduction in paracetamol appearance in the larger meals may be a sign of the GLP-1 induced inhibition of gastric emptying, the ileal brake (42) .
In conclusion, we demonstrate that increasing meal size elicits a caloric-dependent insulin response due to increased ␤-cell secretion achieved by increased GIP and GLP-1 levels to which an initial rapid gastric emptying contributes in combination with educed insulin clearance. The increased insulinemia at the two larger meals perfectly adapts to the caloric demand with higher insulin after larger than medium meal size, resulting in identical glucose excursions. In contrast, after a lower caloric lunch (511 kcal), the insulin response seems to be inappropriately high, resulting in postpeak suppression of glucose below baseline. Based on these findings, we suggest that there is an almost perfect adapting insulin response to caloric demands after mixed lunch meals of medium or large size in healthy humans, whereas a lower calorie meal may need extra carbohydrate content to prevent eliciting a counterregulatory response.
